MORGAN STANLEY - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$19,000
-48.6%
24,041
-47.4%
0.00%
Q4 2021$37,000
-19.6%
45,663
+16.5%
0.00%
Q3 2021$46,000
-32.4%
39,185
-9.5%
0.00%
Q2 2021$68,000
+466.7%
43,285
+781.2%
0.00%
Q1 2021$12,000
-92.8%
4,912
-91.3%
0.00%
Q4 2020$166,000
+730.0%
56,188
+331.6%
0.00%
Q3 2020$20,000
-58.3%
13,019
-31.5%
0.00%
Q2 2020$48,000
+269.2%
18,998
+203.5%
0.00%
Q1 2020$13,000
-94.0%
6,260
-91.1%
0.00%
Q4 2019$217,000
+301.9%
70,324
+331.2%
0.00%
Q3 2019$54,000
+390.9%
16,308
+357.2%
0.00%
Q2 2019$11,000
-68.6%
3,567
-70.4%
0.00%
Q1 2019$35,000
-89.7%
12,035
-85.7%
0.00%
Q4 2018$339,000
-22.1%
84,427
-9.4%
0.00%
Q3 2018$435,000
-64.1%
93,166
-36.7%
0.00%
Q2 2018$1,213,000
+204.8%
147,257
+54.2%
0.00%
Q1 2018$398,000
+182.3%
95,512
+118.2%
0.00%
Q4 2017$141,000
+6950.0%
43,767
+3682.8%
0.00%
Q3 2017$2,000
+100.0%
1,157
+2.1%
0.00%
Q2 2017$1,000
-50.0%
1,133
-16.6%
0.00%
Q1 2017$2,0000.0%1,3580.0%0.00%
Q4 2016$2,000
+100.0%
1,358
+30.5%
0.00%
Q3 2016$1,0000.0%1,041
+2.6%
0.00%
Q2 2016$1,0001,015
+191.7%
0.00%
Q1 2016$0348
+5.8%
0.00%
Q4 2015$0329
+20.5%
0.00%
Q3 2015$0273
-17.0%
0.00%
Q2 2015$0329
+0.6%
0.00%
Q1 2015$0327
-0.3%
0.00%
Q4 2014$0328
+1.5%
0.00%
Q3 2014$03230.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders